Lunatal Dha Capsule, Gelatin Coated
NDC Package 73086-201-30

11-digit billing NDC: 73086020130
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lunatal Dha (ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine hydrochloride, levomefolate calcium, folic acid, cyanocobalamin, biotin, calcium carbonate, iron, potassium iodide, magnesium oxide, fish oil) capsules is classified as a

Identification & Billing

NDC Package Code
73086-201-30
Package Description
30 CAPSULE, GELATIN COATED in 1 BOTTLE
Product Code
73086-201
11-Digit Billing Format
73086020130

Clinical Specifications

Proprietary Name
Lunatal Dha
Non-Proprietary Name
Ascorbic Acid, Cholecalciferol, .alpha.-tocopherol Acetate, Dl-, Pyridoxine Hydrochloride, Levomefolate Calcium, Folic Acid, Cyanocobalamin, Biotin, Calcium Carbonate, Iron, Potassium Iodide, Magnesium Oxide, Fish Oil
Substance Name
Ascorbic Acid; Cholecalciferol; .alpha.-tocopherol Acetate, Dl-; Pyridoxine Hydrochloride; Levomefolate Calcium; Folic Acid; Cyanocobalamin; Biotin; Calcium Carbonate; Iron; Potassium Iodide; Magnesium Oxide; Fish Oil
Dosage Form
Capsule, Gelatin Coated - A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin; through a banding process, the capsule is coated with additional layers of gelatin so as to form a complete seal.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Skya Health, Llc
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
09-04-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73086-201-30 identifies a specific commercial package of 30 capsule, gelatin coated in 1 bottle of Lunatal Dha, a human prescription drug labeled by Skya Health, Llc. This capsule, gelatin coated is formulated for oral use and contains ascorbic acid; cholecalciferol; .alpha.-tocopherol acetate, dl-; pyridoxine hydrochloride; levomefolate calcium; folic acid; cyanocobalamin; biotin; calcium carbonate; iron; potassium iodide; magnesium oxide; fish oil as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Skya Health, Llc on September 04, 2026. The current certification is valid through December 31, 2027.

How is this Skya Health, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73086020130. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73086-201-30
11-Digit CMS (5-4-2)
73086-0201-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.